Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

NCT00661830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Placebo
DRUG: Sorafenib

Sponsor

PD Dr Markus Möhler

Collaborators

[object Object]
[object Object]